“…Mild abnormal liver function tests are common in EPP, but hepatic failure is a rare complication with an incidence between 0% and 16%. 3,[32][33][34][35] However, when biliary secretion, the only route for protoporphyrin, does not keep pace with protoporphyrin production in the bone marrow or liver, progressive accumulation of protoporphyrin occurs, leading to cellular damage, cirrhosis, and rapidly to liver failure. There are 2 main reasons for the alterations of the hepatobiliary system: one is the actual toxicity resulting from the hepatic accumulation of porphyrins, as shown by abnormal liver tests and nonspecific histological alterations such as excess of fat deposition with some degree of fibrosis, sometimes progressing to cirrhosis.…”